Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Seminars in Oncology|December 20, 2005
Microtubule targeting agents: basic mechanisms of multidrug resistance (MDR)Antonio Tito Fojo, Michael Menefee
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2012
Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationaleEdina Komlodi-Pasztor, Dan L Sackett, Antonio Tito Fojo
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 3, 2012
Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studiesLaleh Amiri-Kordestani, Agnes Basseville, Karen Kurdziel, et al.
The Oncologist|January 4, 2021
Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine TumorsClarisse Dromain, Arturo Loaiza-Bonilla, Beloo Mirakhur, et al.
Chemotherapy Research and Practice|February 8, 2012
The Role of Wild-Type p53 in Cisplatin-Induced Chk2 Phosphorylation and the Inhibition of Platinum Resistance with a Chk2 InhibitorXiaobing Liang, Yi Guo, William Douglas Figg, et al.
Journal of Vascular and Interventional Radiology : JVIR|October 31, 2009
Radiofrequency ablation of metastatic pheochromocytomaAradhana M Venkatesan, Julia Locklin, Edwin W Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2012
Analyzing the pivotal trial that compared sunitinib and IFN-α in renal cell carcinoma, using a method that assesses tumor regression and growthWilfred D Stein, Julia Wilkerson, Sindy T Kim, et al.
Breast Cancer Research and Treatment|November 13, 2023
Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trialsCeline Yeh, Mengxi Zhou, Neil Bapodra, et al.
The Oncologist|May 11, 2025
Correlation between tumor growth rate and survival in patients with metastatic breast cancer treated with trastuzumab deruxtecanPhilip He, Dhiraj Gambhire, Haiming Zhou, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Early treatment outcome prediction in metastatic castration-resistant prostate cancer utilizing 3-month tumor growth rate ( <i>g</i> -rate) based machine learning modelEsther C Ugwueke, Mohamed Azzam, Mengxi Zhou, et al.
Pageof 3